EASD 2021 Highlights

(Optional)
Privacy Policy.



Welcome to EASD 2021 Highlights

We are pleased to present the EASD 2021 Highlights produced in collaboration with DESG. The Highlights offer a selection of the newest and most relevant data presented at the EASD Annual Meeting 2021. Enjoy this opportunity to learn about the significant advances and breakthroughs in diabetes research and care.

EASD Faculty Interviews

Learn from some of international experts who contributed to the virtual EASD Annual Meeting 2021.
 
Insulin and the future of diabetes treatment
 
15
What in your opinion are some of the most relevant advances in insulin technology in the last decade?
160
What may be the role of dual GIP and GLP-1 agonists in T2D?
269
What do you think the future will hold in terms of artificial intelligence?
 
Gender differences in cardiovascular risk, treatment, and outcomes: a post-hoc analysis from the REWIND trial
 
15
What were the main findings of the REWIND trial?
63
What are the salient conclusions of this new post-hoc analysis?
177
Are there any clinical implications for daily practice from this new subanalysis
 
Glucose sensors on the rise: new technologies?
 
15
Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität UlmUlm, Germany
124
Are non-invasive methods for glucose-sensing a realistic goal?
190
Can new technologies be expected to expand the demand for use of glucose sensing devices?
See More

Expert Overviews

Expert Overviews on some of the most important sessions and data presented during the EASD Annual Meeting.
 
 
 
 
See More
About DESG Feedback Post test